Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06883175 · ClinicalTrials.gov registry record · NA
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
A NA study of Dysphagia and Achalasia, Esophageal, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 575
- Enrollment target
- 1
- Study location
NCT06883175: Recruiting NA study of Dysphagia and Achalasia, Esophageal, sponsored by Northwestern University.
NCT06883175 is a NA study of Dysphagia and Achalasia, Esophageal that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 575 participants, above the 156-participant average among 35 other Dysphagia trials with a reported enrollment target (269% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06883175, a NA study of Dysphagia and Achalasia, Esophageal, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 575 participants
- Enrollment target
- 1
- Study location
Study Summary
Swallowing difficulties are extremely common and result in substantial morbidity, reduction in the quality of life, and mortality related to malnutrition and complications from regurgitation and aspiration. Unfortunately, our understanding regarding the pathophysiology of dysphagia and GERD has been hampered by focusing predominantly on circular muscle activity and ignoring the essential biomechanical properties of the esophageal wall that promote normal emptying. Our initial work explored the relationship between intrabolus pressure (IBP) and esophagogastric junction (EGJ) compliance as a metric for outflow resistance. This work highlighted the direct relationship between IBP and EGJ opening and was the foundation for the development of the classification scheme utilized around the world to diagnose esophageal motor disorders: "the Chicago Classification" (CC). Despite this improved understanding focused on bolus transit dynamics, there are still significant gaps in our scientific understanding centered on the lack of a true correlate for symptoms, reliable predictive models and effective treatments for Functional dysphagia, IEM and EGJOO. Given these limitations, we have developed novel approaches that combine assessments of primary and secondary peristalsis (a NeuroMyogenic Model of esophageal function). These will leverage our recent findings supporting the importance of the esophageal response to distension in bolus clearance, noting that this response of the esophageal wall to bolus retention or reflux is one of the most essential functions of the esophagus in preventing complications of aspiration, or reflux injury. We will also include an assessment of esophageal geometry and wall biomechanics (elasticity/dilatation) as these carry essential interactions with esophageal function that are overlooked in the current diagnostic paradigms. In order to test our hypothesis that wall mechanics are a major determinant of esophageal diseases, we had to develop new ap
Primary Outcome
A 10 item dysphagia/food impaction questionnaire measured on a 6-point Likert scale from "none" to "severe" with higher scores indicating a greater degree of dysphagia
Conditions Studied
Interventions
- DIAGNOSTIC_TEST FLIP
- DIAGNOSTIC_TEST HRM
- OTHER Prucalopride
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 575 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What NCT06883175 shows while recruiting
NCT06883175 is an interventional study that assigns participants to a tested intervention. The registered 575 participants enrollment target is mid-sized for trials with a published cap, above the 156-participant average among 35 other Dysphagia trials with a reported enrollment target (269% higher).
The record links to 3 conditions, with Dysphagia appearing as the primary indexed condition, and to 3 interventions - of which FLIP is the first listed.
NCT06883175 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06883175 about?
NCT06883175 is a clinical study titled "Evolution of the Chicago Classification: Bridging Physiology and Mechanics". Swallowing difficulties are extremely common and result in substantial morbidity, reduction in the quality of life, and mortality related to malnutrition and complications from regurgitation and aspiration. Unfortunately, our understanding regarding the pathophysiology of dysphagia and GERD has been...
What is the current status of trial NCT06883175?
This trial is currently recruiting. It is a NA study. The enrollment target is 575 participants. The study started on 2024-09-01. Estimated completion is 2029-06-30.
What conditions does trial NCT06883175 study?
This clinical trial studies the following conditions: Dysphagia, Achalasia, Esophageal, Ineffective Esophageal Motility.
What interventions are being tested in trial NCT06883175?
The interventions under investigation include: FLIP (DIAGNOSTIC_TEST), HRM (DIAGNOSTIC_TEST), Prucalopride (OTHER).
Who is sponsoring clinical trial NCT06883175?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06883175 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06883175's enrollment target sits among peer trials
575 4th of 35 higher than 32 of 35 other Dysphagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
RECRUITING · NA
-
Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
-
External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
-
Dysphagia Study Using Novel Microphone Device
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- NCT06583148 · 575 participants · NA
A Smoke-Free Home Intervention in Tribal Communities
- NCT04931810 · 576 participants · NA
Urban and Reservation Implementation of All Nations Breath of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI